The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
In recent years, vaccine development using ribonucleic acid (RNA) has become the most promising and studied approach to produce safe and effective new vaccines, not only for prophylaxis but also as a treatment. The use of messenger RNA (mRNA) as an immunogenic has several advantages to vaccine devel...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/108fa78115ec45d9a3cba35eb8b1af13 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:108fa78115ec45d9a3cba35eb8b1af13 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:108fa78115ec45d9a3cba35eb8b1af132021-11-25T19:11:30ZThe Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview10.3390/vaccines91113452076-393Xhttps://doaj.org/article/108fa78115ec45d9a3cba35eb8b1af132021-11-01T00:00:00Zhttps://www.mdpi.com/2076-393X/9/11/1345https://doaj.org/toc/2076-393XIn recent years, vaccine development using ribonucleic acid (RNA) has become the most promising and studied approach to produce safe and effective new vaccines, not only for prophylaxis but also as a treatment. The use of messenger RNA (mRNA) as an immunogenic has several advantages to vaccine development compared to other platforms, such as lower coast, the absence of cell cultures, and the possibility to combine different targets. During the COVID-19 pandemic, the use of mRNA as a vaccine became more relevant; two out of the four most widely applied vaccines against COVID-19 in the world are based on this platform. However, even though it presents advantages for vaccine application, mRNA technology faces several pivotal challenges to improve mRNA stability, delivery, and the potential to generate the related protein needed to induce a humoral- and T-cell-mediated immune response. The application of mRNA to vaccine development emerged as a powerful tool to fight against cancer and non-infectious and infectious diseases, for example, and represents a relevant research field for future decades. Based on these advantages, this review emphasizes mRNA and self-amplifying RNA (saRNA) for vaccine development, mainly to fight against COVID-19, together with the challenges related to this approach.Bruna Aparecida Souza MachadoKatharine Valéria Saraiva HodelLarissa Moraes dos Santos FonsecaLuís Alberto Brêda MascarenhasLeone Peter Correia da Silva AndradeVinícius Pinto Costa RochaMilena Botelho Pereira SoaresPeter BerglundMalcolm S. DuthieSteven G. ReedRoberto BadaróMDPI AGarticleRNA vaccinesmRNA vaccinessaRNA vaccinesCOVID-19SARS-CoV-2MedicineRENVaccines, Vol 9, Iss 1345, p 1345 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
RNA vaccines mRNA vaccines saRNA vaccines COVID-19 SARS-CoV-2 Medicine R |
spellingShingle |
RNA vaccines mRNA vaccines saRNA vaccines COVID-19 SARS-CoV-2 Medicine R Bruna Aparecida Souza Machado Katharine Valéria Saraiva Hodel Larissa Moraes dos Santos Fonseca Luís Alberto Brêda Mascarenhas Leone Peter Correia da Silva Andrade Vinícius Pinto Costa Rocha Milena Botelho Pereira Soares Peter Berglund Malcolm S. Duthie Steven G. Reed Roberto Badaró The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview |
description |
In recent years, vaccine development using ribonucleic acid (RNA) has become the most promising and studied approach to produce safe and effective new vaccines, not only for prophylaxis but also as a treatment. The use of messenger RNA (mRNA) as an immunogenic has several advantages to vaccine development compared to other platforms, such as lower coast, the absence of cell cultures, and the possibility to combine different targets. During the COVID-19 pandemic, the use of mRNA as a vaccine became more relevant; two out of the four most widely applied vaccines against COVID-19 in the world are based on this platform. However, even though it presents advantages for vaccine application, mRNA technology faces several pivotal challenges to improve mRNA stability, delivery, and the potential to generate the related protein needed to induce a humoral- and T-cell-mediated immune response. The application of mRNA to vaccine development emerged as a powerful tool to fight against cancer and non-infectious and infectious diseases, for example, and represents a relevant research field for future decades. Based on these advantages, this review emphasizes mRNA and self-amplifying RNA (saRNA) for vaccine development, mainly to fight against COVID-19, together with the challenges related to this approach. |
format |
article |
author |
Bruna Aparecida Souza Machado Katharine Valéria Saraiva Hodel Larissa Moraes dos Santos Fonseca Luís Alberto Brêda Mascarenhas Leone Peter Correia da Silva Andrade Vinícius Pinto Costa Rocha Milena Botelho Pereira Soares Peter Berglund Malcolm S. Duthie Steven G. Reed Roberto Badaró |
author_facet |
Bruna Aparecida Souza Machado Katharine Valéria Saraiva Hodel Larissa Moraes dos Santos Fonseca Luís Alberto Brêda Mascarenhas Leone Peter Correia da Silva Andrade Vinícius Pinto Costa Rocha Milena Botelho Pereira Soares Peter Berglund Malcolm S. Duthie Steven G. Reed Roberto Badaró |
author_sort |
Bruna Aparecida Souza Machado |
title |
The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview |
title_short |
The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview |
title_full |
The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview |
title_fullStr |
The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview |
title_full_unstemmed |
The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview |
title_sort |
importance of rna-based vaccines in the fight against covid-19: an overview |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/108fa78115ec45d9a3cba35eb8b1af13 |
work_keys_str_mv |
AT brunaaparecidasouzamachado theimportanceofrnabasedvaccinesinthefightagainstcovid19anoverview AT katharinevaleriasaraivahodel theimportanceofrnabasedvaccinesinthefightagainstcovid19anoverview AT larissamoraesdossantosfonseca theimportanceofrnabasedvaccinesinthefightagainstcovid19anoverview AT luisalbertobredamascarenhas theimportanceofrnabasedvaccinesinthefightagainstcovid19anoverview AT leonepetercorreiadasilvaandrade theimportanceofrnabasedvaccinesinthefightagainstcovid19anoverview AT viniciuspintocostarocha theimportanceofrnabasedvaccinesinthefightagainstcovid19anoverview AT milenabotelhopereirasoares theimportanceofrnabasedvaccinesinthefightagainstcovid19anoverview AT peterberglund theimportanceofrnabasedvaccinesinthefightagainstcovid19anoverview AT malcolmsduthie theimportanceofrnabasedvaccinesinthefightagainstcovid19anoverview AT stevengreed theimportanceofrnabasedvaccinesinthefightagainstcovid19anoverview AT robertobadaro theimportanceofrnabasedvaccinesinthefightagainstcovid19anoverview AT brunaaparecidasouzamachado importanceofrnabasedvaccinesinthefightagainstcovid19anoverview AT katharinevaleriasaraivahodel importanceofrnabasedvaccinesinthefightagainstcovid19anoverview AT larissamoraesdossantosfonseca importanceofrnabasedvaccinesinthefightagainstcovid19anoverview AT luisalbertobredamascarenhas importanceofrnabasedvaccinesinthefightagainstcovid19anoverview AT leonepetercorreiadasilvaandrade importanceofrnabasedvaccinesinthefightagainstcovid19anoverview AT viniciuspintocostarocha importanceofrnabasedvaccinesinthefightagainstcovid19anoverview AT milenabotelhopereirasoares importanceofrnabasedvaccinesinthefightagainstcovid19anoverview AT peterberglund importanceofrnabasedvaccinesinthefightagainstcovid19anoverview AT malcolmsduthie importanceofrnabasedvaccinesinthefightagainstcovid19anoverview AT stevengreed importanceofrnabasedvaccinesinthefightagainstcovid19anoverview AT robertobadaro importanceofrnabasedvaccinesinthefightagainstcovid19anoverview |
_version_ |
1718410137248464896 |